Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

XLCARE PHARMACEUTICALS INC

Subsidiary ofCIPLA USA INCUEI: MEAUS5WHBJJ7CAGE: 86SL9

XLCARE PHARMACEUTICALS INC is a federal contractor, registered under UEI MEAUS5WHBJJ7 and CAGE code 86SL9. It has been awarded $53,570,640 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include Department Of Veterans Affairs.

Contact Information

Registration and classification details

Registration

UEI Code

MEAUS5WHBJJ7

CAGE Code

86SL9

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit OrganizationWoman-Owned BusinessSubcontinent Asian (Asian-Indian) American OwnedMinority-Owned BusinessWomen-Owned Small BusinessDOT Certified DBE

NAICS Codes

325412Pharmaceutical Preparation Manufacturing(Primary)
424210Drugs and Druggists' Sundries Merchant Wholesalers

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

XLCare Pharmaceuticals, Inc. specializes in the manufacturing of sterile and oral pharmaceutical preparations, with deep expertise in the production of generic active pharmaceutical ingredients and finished dosage forms, including tablets, capsules, and injectable solutions. The company demonstrates...

XLCare Pharmaceuticals, Inc. specializes in the manufacturing of sterile and oral pharmaceutical preparations, with deep expertise in the production of generic active pharmaceutical ingredients and finished dosage forms, including tablets, capsules, and injectable solutions. The company demonstrates consistent proficiency in managing complex regulatory compliance workflows for the U.S. Department of Veterans Affairs, particularly around cost recovery fee structures, quarterly sales reporting, and contract modifications tied to FDA-regulated drug products such as levothyroxine, gabapentin, oxcarbazepine, and lacosamide. Their technical capabilities encompass full-cycle pharmaceutical manufacturing, batch record validation, GMP adherence, and seamless integration of federal procurement compliance mechanisms into operational workflows. XLCare Pharmaceuticals maintains an exclusive and enduring relationship with the Department of Veterans Affairs, serving as a trusted supplier of essential generic medications for veteran healthcare programs. All awarded contracts are directly tied to the VA’s pharmaceutical supply chain, where the company supports mission-critical drug availability through reliable production, timely contract modifications, and strict adherence to federal reporting requirements for controlled and non-controlled substances. The contractor’s primary focus is on NAICS 325412 — Pharmaceutical Preparation Manufacturing — positioning them as a niche provider of generic therapeutics within the federal healthcare supply chain. Their specialization lies in high-volume, low-margin generic drugs requiring stringent quality control, regulatory documentation, and supply continuity, making them a critical partner for agencies managing large-scale formularies. As a Women-Owned Small Business and Woman-Owned Business certified firm based in Lawrenceville, Georgia, XLCare Pharmaceuticals leverages its small business status to serve federal procurement goals while maintaining full compliance with cGMP and FDA standards. The company’s geographic presence and certifications enhance its role as a diverse supplier within the government pharmaceutical marketplace.

Key Performance Metrics

Awards Count

27

All time

Active

0

Currently performing

Completed

26

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with XLCARE PHARMACEUTICALS INC

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for XLCARE PHARMACEUTICALS INC

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in XLCARE PHARMACEUTICALS INC's top NAICS codes and agencies

NAICS: 325412
New
DIBBS
ISOPROPYL RUBBING ALCO
Solicitation # SPE2DS-27-T-1126
This solicitation, issued by DLA Troop Support Medical Supply Chain MD SURG FSF under solicitation number SPE2DS-27-T-1126, is for the procurement of one bottle of 70 percent USP Isopropyl Rubbing Alcohol (NSN 6505-01-078-9605). The item must be provided in a one-gallon plastic bottle with a total shelf life of 36 months, requiring a minimum of 31 months of remaining shelf life upon receipt by the government. Delivery is designated as a vessel shipment to the USS VIRGINIA SSN 774, with a required delivery date of November 2, 2026. Inspection and acceptance will occur at the destination. The contract mandates strict adherence to hazardous materials regulations, requiring a current Material Safety Data Sheet (MSDS) to accompany each shipment and electronic submission to DLA. Packaging must comply with RP001 DLA requirements, ASTM D3951, 49 CFR, and either ICAO or IMDG standards. Labeling must follow Medical Marking Standard No. 1A. Additionally, the contractor must ensure that no mercury or mercury-containing compounds are intentionally added to the supplies. Administrative requirements include the use of the Wide Area WorkFlow (WAWF) system for invoicing and compliance with the Buy American and Balance of Payments Program, as well as various DFARS cybersecurity and telecommunications restrictions. All quotes must be submitted via the DLA Internet Bid Board System (DIBBS).
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 9 hours ago

DEADLINE

in 6 days
View Details